Advancing today’s therapies to enable healthier lives
Our ground-breaking technology platform, Arestat™ enables us to develop future medicines from existing therapies, across all disease indications and at any stage of a drug lifecycle
Using our Arestat™ technology platform, we are developing next generation therapies for our proprietary pipeline and in partnership with leading pharmaceutical and biotech companies
Our Products
Our treatments for people living with chronic disease are designed to advance patient care and improve clinical outcomes
Our Partners
We work with many of the top 20 leading pharmaceutical companies to improve their products, find solutions or create next generation products
Latest News and Events
-
21st September 2020
Arecor to present at EASD 2020 – oral presentation of phase I clinical trial of AT247, a novel Ultra Rapid Acting Insulin
-
25th June 2020
Arecor featured in New Scientist’s Business and Industry 2020 Life Sciences campaign – bringing effective and affordable drugs to market more quickly
-
15th June 2020
Arecor presents positive results for the first phase I clinical trial of AT247, a novel ultra-rapid acting insulin